Compounds > 3'-o-(n-methylanthraniloyl) atp
Page last updated: 2024-09-03

3'-o-(n-methylanthraniloyl) atp and Cardiomyopathy, Hypertrophic Obstructive

3'-o-(n-methylanthraniloyl) atp has been researched along with Cardiomyopathy, Hypertrophic Obstructive in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Garfinkel, AC; Gorham, JM; Jiang, J; Liao, D; Lun, M; Lunde, IG; Lynch, TL; McDonough, B; McNamara, JW; Redwood, CS; Sadayappan, S; Seidman, CE; Seidman, JG; Tai, AC; Toepfer, CN; Wakimoto, H; Watkins, HC1

Other Studies

1 other study(ies) available for 3'-o-(n-methylanthraniloyl) atp and Cardiomyopathy, Hypertrophic Obstructive

ArticleYear
Hypertrophic cardiomyopathy mutations in
    Science translational medicine, 2019, 01-23, Volume: 11, Issue:476

    Topics: Adenosine Triphosphate; Animals; Cardiomyopathy, Hypertrophic; Carrier Proteins; Disease Models, Animal; Haploinsufficiency; Humans; Mice; Mutation; Myocardial Contraction; Myocardium; Myocytes, Cardiac; Myosins; ortho-Aminobenzoates; Phenotype

2019